The Potent Antitumor Activity of Smp43 against Non-Small-Cell Lung Cancer A549 Cells via Inducing Membranolysis and Mitochondrial Dysfunction.
Quick Facts
What This Study Found
Smp43 has an IC50 value of 2.58 μM against A549 cells, indicating potent cytotoxicity.
Key Numbers
How They Did This
The study assessed the cytotoxic effects of Smp43 on A549 cells in vitro and evaluated its protective effects in xenograft mice models.
Why This Research Matters
The findings highlight the potential of scorpion venom peptides as novel cancer therapies, particularly for hard-to-treat lung cancers. Understanding how Smp43 works could lead to new treatment strategies.
What This Study Doesn't Tell Us
The study primarily focused on in vitro results, and further research is needed to confirm efficacy and safety in humans.
Trust & Context
- Original Title:
- The Potent Antitumor Activity of Smp43 against Non-Small-Cell Lung Cancer A549 Cells via Inducing Membranolysis and Mitochondrial Dysfunction.
- Published In:
- Toxins, 15(5) (2023)
- Authors:
- Deng, Ze, Gao, Yahua, Nguyen, Tienthanh, Chai, Jinwei, Wu, Jiena, Li, Jiali, Abdel-Rahman, Mohamed A, Xu, Xueqing, Chen, Xin
- Database ID:
- RPEP-06835
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06835APA
Deng, Ze; Gao, Yahua; Nguyen, Tienthanh; Chai, Jinwei; Wu, Jiena; Li, Jiali; Abdel-Rahman, Mohamed A; Xu, Xueqing; Chen, Xin. (2023). The Potent Antitumor Activity of Smp43 against Non-Small-Cell Lung Cancer A549 Cells via Inducing Membranolysis and Mitochondrial Dysfunction.. Toxins, 15(5). https://doi.org/10.3390/toxins15050347
MLA
Deng, Ze, et al. "The Potent Antitumor Activity of Smp43 against Non-Small-Cell Lung Cancer A549 Cells via Inducing Membranolysis and Mitochondrial Dysfunction.." Toxins, 2023. https://doi.org/10.3390/toxins15050347
RethinkPeptides
RethinkPeptides Research Database. "The Potent Antitumor Activity of Smp43 against Non-Small-Cel..." RPEP-06835. Retrieved from https://rethinkpeptides.com/research/deng-2023-the-potent-antitumor-activity
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.